Mohs Surgery an Option for Early-Stage Invasive Melanoma Mohs Surgery an Option for Early-Stage Invasive Melanoma

Mohs micrographic surgery (MMS) may be an effective alternative to wide margin excision (WME) for appropriately selected patients with early-stage invasive melanoma, a large retrospective study suggests.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Medscape Today News Source Type: news

Related Links:

CONCLUSIONS: STAT3-induced upregulation of SNHG17 contributed to the progression of melanoma by promoting the PI3K-AKT signaling. PMID: 31599425 [PubMed - in process]
Source: European Review for Medical and Pharmacological Sciences - Category: Drugs & Pharmacology Tags: Eur Rev Med Pharmacol Sci Source Type: research
Authors: deShazo R, Soltani-Arabshahi R, Krishnasamy S, Langley RG, Kalia S, Ståhle M, Langholff W, Goyal K, Fakharzadeh S, Galindo C, Srivastava B, Krueger G Abstract To the Editor: Patients with psoriasis are at increased risk of developing non melanoma skin cancer (NMSC), including squamous cell carcinoma (SCC) and basal cell carcinoma (BCC).1,2 The risk is especially elevated among those who previously received systemic treatment or phototherapy.2 Systemic treatments, including biologic therapies and methotrexate (MTX), are effective in managing immune-mediated diseases; however, they may increase suscept...
Source: Journal of Drugs in Dermatology - Category: Dermatology Tags: J Drugs Dermatol Source Type: research
Getting a reliable diagnosis of melanoma can be a significant challenge for pathologists. The diagnosis relies on a pathologist ’s visual assessment of biopsy material on microscopic slides, which can often be subjective. Now, UCLA researchers have found that obtaining a second opinion from pathologists who are board certified or have fellowship training in dermatopathology can help improve the accuracy and reliability of diagnosing melanoma, one of the deadliest and most aggressive forms of skin cancer.“A diagnosis is the building block on which all other medical treatment is based,” said Dr. Joann ...
Source: UCLA Newsroom: Health Sciences - Category: Universities & Medical Training Source Type: news
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Family Medicine, Oncology, News, Source Type: news
Conditions:   Melanoma;   Non-melanoma Skin Cancer Intervention:   Device: Deep Ensemble for the Recognition of Malignancy (DERM) Sponsors:   Skin Analytics Limited;   Innovate UK Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Malignant Melanoma Interventions:   Genetic: delolimogene mupadenorepvec;   Biological: atezolizumab Sponsors:   Lokon Pharma AB;   Precision Oncology LLC Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Melanoma;   Non-melanoma Skin Cancer Intervention:   Device: Deep Ensemble for the Recognition of Malignancy (DERM) Sponsors:   Skin Analytics Limited;   Innovate UK Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Malignant Melanoma Interventions:   Genetic: delolimogene mupadenorepvec;   Biological: atezolizumab Sponsors:   Lokon Pharma AB;   Precision Oncology LLC Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Authors: Albano D, Familiari D, Fornito MC, Scalisi S, Laudicella R, Galia M, Grassedonio E, Ruggeri A, Ganduscio G, Messina M, Spada M, Midiri M, Alongi P Abstract OBJECTIVE: The aim of this retrospective multicenter study was to evaluate the clinical and prognostic impact of 18F-FDG-PET/CT in the restaging process of cutaneous melanoma (CM) after surgery in patients with suspected distant recurrent disease or suspected metastatic progression disease. MATERIALS AND METHODS: 74 patients surgically treated for CM underwent 18F-FDG-PET/CT for suspicious of distant recurrent disease or suspected metastatic progres...
Source: Current Radiopharmaceuticals - Category: Radiology Tags: Curr Radiopharm Source Type: research
FRIDAY, Oct. 11, 2019 -- Melanoma is the most lethal type of skin cancer, and a new study finds that the diagnosis of a suspect lesion gains accuracy when a specialist pathologist is brought on board. Many patients with melanoma are first diagnosed...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
More News: Health | Melanoma | Skin Cancer | Study